Faeth Therapeutics, Inc <FTH.O>: JonesTrading initiates coverage with buy rating; target price $55
FTH•Related News
Pinnacle West Q2 profit misses estimates on higher costs
PNW•
Wave Life Sciences CEO to speak at BofA Securities SMID Cap Executive Insights event
WVE•
Apollo debt deal fees and insurance earnings rise, asset sales drag
APO•
MaxLinear, Core Micro Systems collaborate on Panther-based hardware-accelerated OpenZFS storage solutions
MXL•
Bicara Therapeutics to report Q2 results, provide business update in conference call
BCAX•